Department of Cardiovascular Sciences & National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), University of Leicester, Glenfield Hospital, Leicester, UK.
Leicester Vascular Institute, Glenfield Hospital, Leicester, UK.
Br J Surg. 2021 Oct 23;108(10):1192-1198. doi: 10.1093/bjs/znab220.
Population-wide ultrasound screening programmes for abdominal aortic aneurysm (AAA) for men have already been established in some countries. Women account for one third of aneurysm-related mortality and are four times more likely to experience an AAA rupture than men. Whole-population screening for AAA in women is unlikely to be clinically or economically effective. The aim of this study was to determine the outcomes of a targeted AAA screening programme for women at high risk of AAA.
Women aged 65-74 years deemed at high risk of having an AAA (current smokers, ex-smokers, or with a history of coronary artery disease) were invited to attend ultrasound screening (July 2016 to March 2019) for AAA in the Female Aneurysm screening STudy (FAST). Primary outcomes were attendance for screening and prevalence of AAA. Biometric data, medical history, quality of life (QoL) and aortic diameter on ultrasound imaging were recorded prospectively.
Some 6037 women were invited and 5200 attended screening (86.7 per cent). Fifteen AAAs larger than 29 mm were detected (prevalence 0.29 (95 per cent c.i. 0.18 to 0.48) per cent). Current smokers had the highest prevalence (0.83 (95 per cent c.i. 0.34 to 1.89) per cent) but lowest attendance (75.2 per cent). Three AAAs greater than 5.5 cm were identified and referred for consideration of surgical repair; one woman underwent repair. There was a significant reduction in patient-reported QoL scores following screening.
A low prevalence of AAA was detected in high-risk women, with lowest screening uptake in those at highest risk. Screening for AAA in high-risk women may not be beneficial.
一些国家已经为男性开展了全人群腹主动脉瘤(AAA)超声筛查项目。女性占动脉瘤相关死亡率的三分之一,发生 AAA 破裂的可能性是男性的四倍。对女性进行全人群 AAA 筛查不太可能在临床上或经济上有效。本研究旨在确定针对高危女性 AAA 的靶向 AAA 筛查计划的结果。
年龄在 65-74 岁之间、有 AAA 风险(当前吸烟者、曾经吸烟者或有冠心病史)的女性被邀请参加女性动脉瘤筛查研究(FAST)的超声筛查(2016 年 7 月至 2019 年 3 月)。主要结局是筛查的参与度和 AAA 的患病率。前瞻性记录了生物计量数据、病史、生活质量(QoL)和超声成像上的主动脉直径。
共邀请了 6037 名女性,有 5200 名女性参加了筛查(86.7%)。发现了 15 个大于 29 毫米的 AAA(患病率为 0.29%(95%置信区间 0.18% 至 0.48%))。目前吸烟者的患病率最高(0.83%(95%置信区间 0.34% 至 1.89%)),但参与率最低(75.2%)。发现了 3 个大于 5.5 厘米的 AAA,并考虑手术修复;一名女性接受了修复。筛查后患者报告的 QoL 评分显著下降。
在高危女性中发现 AAA 的患病率较低,而风险最高的女性的筛查参与率最低。对高危女性进行 AAA 筛查可能无益。